Pola Orbis Holdings Inc. (TYO:4927)
Japan
· Delayed Price · Currency is JPY 1,319.00
-1.00 (-0.08%)
Mar 10, 2026, 9:24 AM JST
Pola Orbis Holdings Revenue
In the year 2025, Pola Orbis Holdings had annual revenue of 170.29B JPY, down -0.04%. Pola Orbis Holdings had revenue of 45.28B in the quarter ending December 31, 2025, with 0.71% growth.
Revenue
170.29B
Revenue Growth
-0.04%
P/S Ratio
1.72
Revenue / Employee
42.35M
Employees
4,021
Market Cap
292.07B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 170.29B | -74.00M | -0.04% |
| Dec 31, 2024 | 170.36B | -2.95B | -1.70% |
| Dec 31, 2023 | 173.30B | 7.00B | 4.21% |
| Dec 31, 2022 | 166.31B | -12.34B | -6.90% |
| Dec 31, 2021 | 178.64B | 2.33B | 1.32% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Paltac | 1,227.67B |
| KOSE Holdings | 330.19B |
| MTG Co., Ltd. | 109.56B |
| Kobayashi Pharmaceutical | 165.74B |
| Pigeon | 109.17B |
| Lion Corporation | 422.09B |
| Rohto Pharmaceutical | 335.80B |
| Noevir Holdings | 63.39B |